American Beacon ARK Transformational Innovation Fund R5 Class ADNIX

Morningstar Medalist Rating
  • NAV / 1-Day Return$20.06  /  −1.00%
  • Fund Size$135.4M
  • Adjusted Expense Ratio1.000%
  • Net Expense Ratio1.010%
  • Fee Level: DistributionHigh
  • Share Class TypeRetirement, Large
  • Morningstar CategoryTechnology
  • Equity Style Box (Funds)Large Growth
  • Minimum Initial Investment$250,000
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio47%

Morningstar’s Analysis ADNIX

Will ADNIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still fragile, but firmer around the edges.

Principal Robby Greengold

Robby Greengold

Principal

Summary

ARK Innovation’s investment team promises investors a front-row seat to the future, and its broad calls on technologies such as artificial intelligence, biotechnology, and robotics have often been directionally correct. However, it hasn’t shown a strong ability to identify the themes’ biggest winners while prudently managing the portfolio’s extreme risks.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ADNIX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings49.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Tesla Inc

9.1216M
Consumer Cyclical

Space Exploration Technologies Corp Class A

6.2011M
Industrials

Tempus AI Inc Class A common stock

5.6710M
Healthcare

Coinbase Global Inc Ordinary Shares - Class A

4.939M
Financial Services

Circle Internet Group Inc Ordinary Shares - Class A

4.768M
Financial Services

CRISPR Therapeutics AG

4.388M
Healthcare

U.S. Government Money Market S

4.308M
Cash and Equivalents

Twist Bioscience Corp

4.187M
Healthcare

Robinhood Markets Inc Class A

3.727M
Financial Services

10x Genomics Inc Ordinary Shares - Class A

3.136M
Healthcare

Sponsor Center